Junevity

Seed
junevity.com Biotech & Healthcare San Francisco, United States
Total Funding $20M
Latest Round $20M Seed
Last Announced Dec 3, 2025
Investors 3 Backers
Decision Makers 3 Verified

About Junevity

Junevity develops medicines targeting transcription factors to reverse diseases of aging.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters San Francisco, United States
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website junevity.com
Domain Registered Date Mar 15, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $20,000,000 · Seed

    fundraisingfox.com

  2. Capital Raise

    Seed announced

    fundraisingfox.com

  3. Milestone

    Website domain registered

    junevity.com

Investors & Backers

3
AMOREPACIFIC Ventures
Godfrey Capital
Goldcrest Capital

Funding History

2 Rounds
Seed · Dec 3, 2025
Seed · Feb 13, 2025

Founders & Leadership

2

Janine Sengstack

Founder

Work email & phone locked Unlock →

John Hoekman

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts